À propos de StandardX
StandardX conçoit une plateforme compacte d’accélérateur de particules haute puissance, destinée à produire plusieurs isotopes à partir d’une installation standardisée. Fondée en 2025, l’entreprise se concentre d’abord sur l’approvisionnement en isotopes pour le diagnostic et le traitement du cancer, la recherche et les futurs systèmes de fusion.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.